A Phase 1 Randomized Observer-Blind Study to Evaluate the Safety And Tolerability of a Vaccine Candidate Against Respiratory Syncytial Virus in Healthy Individuals 18 Through 49 Years of Age
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Healthy ParticipantsRsv
-
Age: Between 18 Year(s) - 49 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Participants who are willing and able to comply with all scheduled visits, investigational plan, laboratory tests, lifestyle considerations, and other study procedures.
- Participants who can give signed informed consent.
You may not be eligible for this study if the following are true:
-
- History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the study intervention(s).
- Immunocompromised individuals with known or suspected immunodeficiency, as determined by history and/or laboratory/physical examination.
- . Prior history of heart disease, including prior diagnosis of coronary artery disease, uncontrolled hypertension, atrial fibrillation, heart failure, myocarditis, or pericarditis.
- Women who are pregnant, plan to become pregnant during the study, or are breastfeeding.
- Participants with a history of autoimmune disease or an active autoimmune disease, including but not limited to systemic or cutaneous lupus erythematosus, autoimmune arthritis/rheumatoid arthritis, Guillain-Barré syndrome, multiple sclerosis, Sjögren’s syndrome, idiopathic thrombocytopenia purpura, glomerulonephritis, autoimmune thyroiditis, temporal arteritis, psoriasis, and/or insulin-dependent diabetes mellitus.
- Known infection with HIV, HCV, or HBV.
- Prior receipt of investigational or licensed RSV vaccine.
- Participants with a calculated BMI of ≤ 18 or ≥ 35 kg/m2.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.